STA®-Liatest® D-Di Plus, Less interferences for even More Confidence
As part of Stago's continuous improvement commitment, STA® -Liatest® D-Di Plus* was developed as an evolution of the STA® -Liatest® D-Di, one of the most published D-Dimer assays, also FDA approved for aid in the diagnosis of Venous ThromboEmbolism (VTE).
Read more
STA®-Liquid Fib is the lastest innovation in our routine line. This new liquid reagent for the quantitative determination of fibrinogen levels is based on the reference Clauss clotting method combined with the mechanical clot detection system. STA®-Liquid Fib is a practical and robust reagent designed to give reliable results.
Read more
STA Compact Max®: Innovation born from Expertise
STA Compact Max® is the new generation of analyser developed by the Coagulation Company to meet labs' expectations.
Read more
STA®-ImmunoDef VIII & STA®-ImmunoDef IX
As part of Stago's continuous improvement commitment, STA®-ImmunoDef VIII* & STA®-ImmunoDef IX* kits have been developed as a new generation of Deficient Plasmas with enhanced performance. Factors VIII and IX measurement allows characterising clinically significant conditions such as Haemophilia A and B. Robust and reliable reagents should be available for an easier daily laboratory practice.
Read more
STA®-Liatest® FM, the new marker for DIC
To better diagnose DIC and for a reliable vital prognosis, Stago has developed STA®-Liatest® FM, a new quantitative and fully-automated assay for fibrin monomers determination.
Read more